Immediate Impact
2 by Nobel laureates 3 from Science/Nature 53 standout
Citing Papers
How I Treat Refractory CRS and ICANS Following CAR T-cell Therapy
2023 Standout
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
Works of Paul N. Meyer being referenced
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Paul N. Meyer | 389 | 64 | 166 | 278 | 196 | 19 | 651 | |
| S. Öhl | 373 | 42 | 209 | 234 | 259 | 19 | 764 | |
| CR Kjeldsberg | 509 | 19 | 138 | 341 | 230 | 23 | 707 | |
| Stephan Schwarz | 228 | 105 | 110 | 182 | 195 | 20 | 663 | |
| Eva Cristóbal | 364 | 65 | 120 | 266 | 159 | 29 | 699 | |
| Maria Scardoni | 253 | 83 | 173 | 422 | 84 | 21 | 815 | |
| P Algara | 565 | 51 | 79 | 339 | 346 | 19 | 713 | |
| H Weinstein | 287 | 69 | 149 | 192 | 78 | 23 | 691 | |
| Lippman Sm | 322 | 46 | 339 | 215 | 122 | 15 | 792 | |
| Ilse Christiansen | 432 | 24 | 187 | 222 | 228 | 31 | 771 | |
| J H Glick | 246 | 142 | 82 | 284 | 128 | 23 | 608 |
All Works
Loading papers...